Beyond Antibiotics (EIN 831983463) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2018

Legal Domicile

Principal Officer

William E Brown

Phone

4154217555

Tax Period

2023-01-01 to 2023-12-31

Beyond Antibiotics, founded in 2018, is a small nonprofit in the Medical Research sector that reported $350K in total revenue in fiscal year 2023. Revenue surged 990% from the prior year, signaling strong growth momentum. The organization ran a surplus of $141K, a strong 40% operating margin.

Mission

Beyond Antibiotics is dedicated to advancing research in the area of compounds, such as antimicrobial or antimicrobial-like substances, and other efforts that prevent and protect against infectious diseases and improve overall human and animal health.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $350,000

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $350,000

Expense Breakdown

Grants Paid $200,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $208,467

Other Expenses $9,406

TOTAL EXPENSES $209,406

Year-over-Year Comparison

	2023	2022	Change
Revenue	$350,000	$32,118	+9.9%
Expenses	$209,406	$65,236	+2.2%
Net Income	$140,594	$-33,118	-5.2%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
William E Brown	President	2.00	Officer	$0	$0	$0
Jill DeMichiel	Sec/Treas	2.00	Officer	$0	$0	$0
Sharon Bonner-Brown	Director	2.00		$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2023	$350,000	$209,406	$328,394	$140,594
2021	$200,000	$217,466	$207,174	$-17,466
2020	$405,000	$189,941	$224,640	$215,059

Beyond Antibiotics